Page last updated: 2024-11-08

biguanides and Atrophy

biguanides has been researched along with Atrophy in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
" Six others had the abrupt onset of a dense cataract, including 5 with iris atrophy, that occurred during the initial 6 months of therapy with chlorhexidine, a diamidine, and adjunctive corticosteroid."3.74Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. ( Herz, NL; Matoba, AY; Wilhelmus, KR, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herz, NL1
Matoba, AY1
Wilhelmus, KR1

Other Studies

1 other study available for biguanides and Atrophy

ArticleYear
Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis.
    Ophthalmology, 2008, Volume: 115, Issue:5

    Topics: Acanthamoeba Keratitis; Administration, Topical; Adult; Aged; Antiprotozoal Agents; Atrophy; Benzami

2008